Possible mechanism of the potent vasoconstrictor responses to ryanodine in dog cerebral arteries

European Journal of Pharmacology

Volumn 311, Issue 1, 1996, Pages 53-60

  Asano, Masahisa ^a   Kuwako, Miho ^a   Nomura, Yukiko ^a   Suzuki, Yoshio ^b   Shibuya, Masato ^b   Sugita, Kenichiro ^b   Katsuaki, Ito ^c  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Arterial myogenic tone; Ca2+ channel; Ca2+ buffering function; Cerebral artery; Dog; Ryanodine; Sarcoplasmic reticulum; Voltage dependent

Indexed keywords

CAFFEINE; CALCIUM CHANNEL; CROMAKALIM; NIFEDIPINE; PAPAVERINE; PHENOXYBENZAMINE; RYANODINE; TIMOLOL; TIMOLOL MALEATE;

ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; FEMALE; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; VASOCONSTRICTION;

EID: 0030571008     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00408-6     Document Type: Article

References (33)

1. Allen, G.S. and S.B. Banghart, 1979, Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries, Neurosurgery 4, 37.
2. Asano, M., K. Aoki, Y. Suzuki and T. Matsuda, 1987, Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries, J. Pharmacol. Exp. Ther. 243, 645.
3. Asano, M., K. Masuzawa and T. Matsuda, 1988, Evidence for reduced β-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats, Br. J. Pharmacol. 94, 73.
4. + channels in the resting state of cerebral, coronary and mesenteric arteries of the dog, J. Pharmacol. Exp. Ther. 267, 1277.
5. + channels in dog basilar artery, J. Cereb. Blood Flow Metab. 13, 969.
6. Cauvin, C., R. Loutzenhiser and C. Van Breemen, 1983, Mechanisms of calcium antagonist-induced vasodilation, Annu. Rev. Pharmacol. Toxicol. 23, 373.
7. Chen, Q., M. Cannell and C. Van Breemen, 1992, The superficial buffer barrier in vascular smooth muscle, Can. J. Physiol. Pharmacol. 70, 509.
8. 2+ release channels with ryanodine in junctional terminal cisternae of sarcoplasmic reticulum of fast skeletal muscle, Proc. Natl. Acad. Sci. USA 82, 7256.
9. Fujiwara, S., T. Itoh and H. Suzuki, 1982, Membrane properties and excitatory neuromuscular transmission in the smooth muscle of dog cerebral arteries, Br. J. Pharmacol. 77, 197.
10. Hirst, G.D.S. and F.R. Edwards, 1989, Sympathetic neuroeffector transmission in arteries and arterioles, Physiol. Rev. 69, 546.
11. 45Ca efflux and tension in rabbit aortic smooth muscle, Pflügers Arch. 408, 343.
12. Iino, M., T. Kobayashi and M. Endo, 1988, Use of ryanodine for functional removal of the calcium store in smooth muscle cells of the guinea-pig, Biochem. Biophys. Res. Commun. 152, 417.
13. 2+ release in contractions of intact vascular smooth muscle, Am. J. Physiol. 261, H1464.
14. Kanmura, Y., L. Missiaen, L. Raeymaekers and R. Casteels, 1988, Ryanodine reduces the amount of calcium in intracellular stores of smooth-muscle cells of the rabbit ear artery, Pflügers Arch. 413, 153.
15. Kou, K., H. Kuriyama and H. Suzuki, 1982, Effects of 3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran (K-351) on smooth muscle cells and neuromuscular transmission in the canine mesenteric artery, Br. J. Pharmacol. 77, 679.
16. 45Ca efflux in rabbit mesenteric small artery, Br. J. Pharmacol, 87, 739.
17. 86Rb efflux in canine arterial smooth muscle, Br. J. Pharmacol. 103, 1033.
18. Meisheri, K.D. and C. Van Breemen, 1982, Effects of β-adrenergic stimulation on calcium movement in rabbit aortic smooth muscle: relationship with cyclic AMP, J. Physiol. 331, 429.
19. 2+ pathways in smooth muscle plasmalemma, J. Membr. Biol. 59, 19.
20. Naganobu, K., M. Takagi, H. Kawasaki and K. Ito, 1994, Modification by cyclopiazonic acid and ryanodine of depolarization-induced contraction in rat mesenteric artery, Eur. J. Pharmacol. 251, 307.
21. Nelson, M.T., J.B. Patlak, J.F. Worley and N.B. Standen, 1990, Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am. J. Physiol. 259, C3.
22. Ozaki, H., H. Kasai, M. Hori, K. Sato, H. Ishihara and H. Karaki, 1990, Direct inhibition of chicken gizzard smooth muscle contractile apparatus by caffeine, Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 262.
23. 2+ release channel, Am. J. Physiol. 253, C364.
24. 2+ levels in vascular smooth muscle of rat aorta, Naunyn-Schmiedeberg's Arch. Pharmacol. 338, 443.
25. Shimizu, K., T. Ohta and N. Toda, 1980, Evidence for greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripheral arteries, Stroke 11, 261.
26. 2+ in the contractile action of endothelin-1 on cerebral, coronary and mesenteric arteries of the dog, Eur. J. Pharmacol. 219, 401.
27. Tanoi, C., Y. Suzuki, M. Shibuya, K. Sugita, K. Masuzawa and M. Asano, 1991, Mechanism of the enhanced vasoconstrictor responses to endothelin-1 in canine cerebral arteries, J. Cereb. Blood Flow Metab. 11, 371.
28. Towart, R., 1981, The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine, Circ. Res. 48, 650.
29. Uski, T.K. and K.-E. Andersson, 1985, Some effects of the calcium promotor BAY K 8644 on feline cerebral arteries, Acta Physiol. Scand. 123, 49.
30. 2+ requirement for activation of intact aortic smooth muscle, J. Physiol. 272, 317.
31. i smooth muscle, Annu. Rev. Physiol. 51, 315.
32. Van Breemen, C., Q. Chen and I. Laher, 1995, Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum, Trends Pharmacol. Sci. 16, 98.
33. Watanabe, C., H. Yamamoto, K. Hirano, S. Kobayashi and H. Kanaide, 1992, Mechanisms of caffeine-induced contraction and relaxation of rat aortic smooth muscle, J. Physiol. 456, 192.